RIANA Therapeutics

Private

ViennaHealthcare & Life Scienceshttps://rianatx.com/

Last Round

Seed

Feb 19, 2026

Total Funding Raised

$1.95M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

RIANA Therapeutics is a biotechnology company that develops small-molecule cancer therapies targeting protein-protein interactions in transcription factors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

small-molecule inhibitoracute myeloid leukemiaAMLSTAT5 inhibitorphenotypic drug discoveryprotein-protein interactionsPPIoncology biotechdrug discovery platformhematologic malignanciespre-clinical developmenthit-to-leadbiotech spin-offdrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RIANA Therapeutics Comparables

Compare RIANA Therapeutics with similar companies based on industry and business-model similarity.

RIANA Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Eli Lilly and Company	79%
Bayer AG	79%
CORE Biomedicine	76%

View all Comparables

RIANA Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Feb 19, 2026
Grant	Feb 1, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Anna Orlova🇺🇦

CEO and co-founder

Founding Team

RIANA Therapeutics Investors

Notable investors and investment history

RIANA Therapeutics investors
Investor	Rounds
Vienna Business Agency	Grant
Austria Wirtschaftsservice	Grant
FFG Austrian Research Promotion Agency	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 19, 2026
$1.43M round raised

View all signals

RIANA Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

RIANA Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about RIANA Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersVienna

Employee Range7

Year Founded2023

Last FundingFeb 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.